{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T20:41:04Z","timestamp":1665002464576},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The treatment of moderate functionalmitral regurgitation (FMR) during coronary artery bypass grafting (CABG) is still debated. Our primary end point was to assess the improvement of \u201cmitral valve reserve\u201d (MVR) after CABG alone as a clinical demonstration of left ventricular (LV) recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Between June 2019 and June 2021, we prospectively enrolled 104 consecutive patients undergoing CABG with moderate FMR. Inclusion criteria were inferior-posterior-lateral wall hypokinesia and revascularization of the circumflex or right coronary artery. MVR was calculated as the ratio between anterior and posterior leaflets\u2019 straight length. All patients were followed for 1 year. The improvement of MVR has been considered as a reduction of the ratio between anterior and posterior leaflets straight length.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to baseline, mean MVR was significantly reduced both at 6 (2.24\u2009\u00b1\u20090.95 vs. 1,91\u2009\u00b1\u20090.6; p\u2009=\u20090,047) and 12 months follow-up (2.24\u2009\u00b1\u20090.95 vs. 1,69\u2009\u00b1\u20090.49; p\u2009=\u20090,006). Left ventricular (LV) reverse remodeling, meant as improvement of LV ejection fraction and reduction of LV end-systolic volume index and mitral anulus diameter were evaluated at 6 months and 1 year. Mitral regurgitation grade were also significantly reduced at 6 months (p\u2009&lt;\u2009.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The benefits of myocardial revascularization in term of improvement of mitral regurgitation\u2019s degree can be explained by the changes of MVR. The patients with FMR, who could have more advantages from CABG alone, should be the ones who have LVESVi just moderately increased.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01993-6","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T20:02:22Z","timestamp":1665000142000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of changes in \u201cmitral valve reserve\u201d after coronary artery bypass grafts in patients with functional mitral regurgitation"],"prefix":"10.1186","volume":"17","author":[{"given":"Fabrizio","family":"Ceresa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Micari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino Salvatore","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liborio","family":"Mammana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Vizzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Patan\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/01.CIR.0000151097.30779.04","volume":"111","author":"F Bursi","year":"2005","unstructured":"Bursi F, Enriquez-Sarano M, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295\u2013301.","journal-title":"Circulation"},{"key":"1993_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.CIR.96.3.827","volume":"96","author":"GA Lamas","year":"1997","unstructured":"Lamas GA, Mitchell GF, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997;96:827\u201333.","journal-title":"Circulation"},{"key":"1993_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11886-002-0024-6","volume":"4","author":"RA Levine","year":"2002","unstructured":"Levine RA, Hung J, et al. Mechanist insights into functional mitral regurgitation. Curr Cardiol Rep. 2002;4:125\u20139.","journal-title":"Curr Cardiol Rep"},{"key":"1993_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.euje.2004.03.001","volume":"5","author":"E Agricola","year":"2004","unstructured":"Agricola E, Oppizzi M, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr. 2004;5:326\u201334.","journal-title":"Eur J Echocardiogr"},{"key":"1993_CR5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.athoracsur.2009.12.061","volume":"89","author":"G Gogoladze","year":"2010","unstructured":"Gogoladze G, Dellis SL, et al. Analysis of the mitral coaptation zone in normal and functional regurgitant valves. Ann Thorac Surg. 2010;89:1158\u201362.","journal-title":"Ann Thorac Surg"},{"key":"1993_CR6","unstructured":"2021. ESC\/EACTS Guidelines for management of valvular heart disease."},{"key":"1993_CR7","unstructured":"2020 ACC\/AHA Guidelines for management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Otto CM, Nishimura RA, et al Circulation 2020, Vol.143, no 5."},{"key":"1993_CR8","unstructured":"Mahmood F. The role of preoperative mitral imaging in surgical decision making. 68th International Congress of European Society of Cardiovascular and EndoVascular Surgery. Groningen, Netherland, 22\u201325 May 2019."},{"key":"1993_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.96.6.1826","volume":"96","author":"S He","year":"1997","unstructured":"He S, Fontaine AA, et al. Integrated mechanism for functional mitral regurgitation leaflets restriction versus coapting forces in vitro studies. Circulation. 1997;96:1826\u201334.","journal-title":"Circulation"},{"key":"1993_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.CIR.102.12.1400","volume":"102","author":"S Yiu","year":"2000","unstructured":"Yiu S, Enriquez-Sarano M, et al. Determination of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400\u20136.","journal-title":"Circulation"},{"key":"1993_CR11","doi-asserted-by":"publisher","first-page":"i11","DOI":"10.1093\/ejechocard\/jeq121","volume":"11","author":"S Ray","year":"2010","unstructured":"Ray S. The echocardiographic assessment of functional mitral regurgitation. Eur J Echocardiography. 2010;11:10, i11\u20137.","journal-title":"Eur J Echocardiography"},{"key":"1993_CR12","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","volume":"371","author":"PK Smith","year":"2014","unstructured":"Smith PK, Puskas JD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178\u201388.","journal-title":"N Engl J Med"},{"issue":"3","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.athoracsur.2021.03.106","volume":"113","author":"K Fattouch","year":"2022","unstructured":"Fattouch K, Dioguardi P, Guccione F, et al. 10-Years results of mitral repair and coronary bypass for ischemic regurgitation: a randomized trial. Ann Thorac Surg. 2022;113(3):816\u201322.","journal-title":"Ann Thorac Surg"},{"key":"1993_CR14","doi-asserted-by":"crossref","unstructured":"Khallaf A, Elzayadi M, Alkady H, El Naggar A. Results of coronary bypass grafting alone versus combined surgical revascularization and mitral repair in patients with moderate ischemic mitral regurgitation. Heart Surg Forum. 2020 May 5;23(3):e270\u2013e 275.","DOI":"10.1532\/hsf.2773"},{"key":"1993_CR15","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","volume":"374","author":"RE Michler","year":"2016","unstructured":"Michler RE, Smith PK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932\u201341.","journal-title":"N Engl J Med"},{"key":"1993_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","volume":"45","author":"AU Wu","year":"2005","unstructured":"Wu AU, Aaronson KD, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular dysfunction. J Am Coll Cardiol. 2005;45:381\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1993_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.athoracsur.2004.03.022","volume":"78","author":"MD Diodato","year":"2004","unstructured":"Diodato MD, Moon MR, et al. Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg. 2004;78:794\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1993_CR18","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.jacc.2007.02.043","volume":"49","author":"T Mihaljevic","year":"2007","unstructured":"Mihaljevic T, Lam BK, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic regurgitation. J Am Coll Cardiol. 2007;49:2191\u2013201.","journal-title":"J Am Coll Cardiol"},{"key":"1993_CR19","doi-asserted-by":"crossref","unstructured":"Mallidi HR, Pelletier MP, et al. Late outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting. J. Thorac CardioVasc Surg, 2004;127:1187\u20131194.","DOI":"10.1016\/j.jtcvs.2003.09.010"},{"key":"1993_CR20","doi-asserted-by":"crossref","unstructured":"Kang DH, Kim MJ, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation, 2006;114(Suppl):I499-I503.","DOI":"10.1161\/CIRCULATIONAHA.105.000398"},{"key":"1993_CR21","doi-asserted-by":"crossref","unstructured":"Seese L, Deitz R, Dufendach K, et al. Midterm outcomes of isolated coronary bypass grafting in the setting of moderate ischemic mitral regurgitation. J. Surg Res 2022; Oct, 278: 317\u2013324.","DOI":"10.1016\/j.jss.2022.04.043"},{"key":"1993_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1010-7940(01)00770-9","volume":"20","author":"T Ryd\u00e9n","year":"2001","unstructured":"Ryd\u00e9n T, Bech-Hanssen O, et al. The importance if grade 2 ischemic mitral regurgitation in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2001;20:276\u201381.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1993_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.athoracsur.2005.03.034","volume":"80","author":"DR Wong","year":"2005","unstructured":"Wong DR, Agnihotri AK, et al. Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;80:570\u20137.","journal-title":"Ann Thorac Surg"},{"key":"1993_CR24","doi-asserted-by":"crossref","unstructured":"Kang DH, Kim MJ, Kang SJ, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation 2006;114:Suppl:I-499\u2013I-503.","DOI":"10.1161\/CIRCULATIONAHA.105.000398"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01993-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T20:03:50Z","timestamp":1665000230000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01993-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01993-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research has been performed in accordance with the Declaration of Helsinki.We have only collected the data of patients and we have followed them for about two years. We have obtained for each patients a written informed consent to treat their data.The policy of our Hospital doesn\u2019t require a Ethics Committee approval for this type of study because we have treated all patients according to current guidelines. Our aim was to analyze the changes of mitral valve reserve and not to validate a new therapy or a treatment off-label.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"255"}}